Asymptomatic pulmonary cryptococcosis in a patient with Crohn's disease on infliximab: case report

Inflamm Bowel Dis. 2011 Jul;17(7):1637-8. doi: 10.1002/ibd.21564. Epub 2010 Dec 3.

Authors

Fumihito Hirai, Toshiyuki Matsui, Yukiko Ishibashi, Daijirou Higashi, Kitarou Futami, Seiji Haraoka, Akinori Iwashita

PMID: 21674724
DOI: 10.1002/ibd.21564

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Anti-Inflammatory Agents / adverse effects*
Antibodies, Monoclonal / adverse effects*
Asymptomatic Diseases
Cryptococcosis / chemically induced*
Cryptococcosis / diagnosis
Cryptococcosis / microbiology
Cryptococcus neoformans / pathogenicity*
Humans
Infliximab
Lung Diseases, Fungal / chemically induced*
Lung Diseases, Fungal / diagnosis
Lung Diseases, Fungal / microbiology
Male
Prognosis
Tomography, X-Ray Computed
Tumor Necrosis Factor-alpha / antagonists & inhibitors
Tumor Necrosis Factor-alpha / immunology

Substances

Anti-Inflammatory Agents
Antibodies, Monoclonal
Tumor Necrosis Factor-alpha
Infliximab